Tirzepatide (dual GLP-1/GIP receptor agonist): In the SURMOUNT-1 trial, participants on the highest tirzepatide dose (15 mg) achieved approximately 22.5% body weight reduction at 72 weeks
Effectiveness Semaglutide belongs to a class of drugs called glucagon-like peptide 1 receptor agonists (GLP-1 RAs)
Potential Mechanisms in Preclinical Research BPC-157 is a multitasker, as revealed in animal and cell-based research
The most common side effects associated with Ozempic include nausea, vomiting, diarrhea, constipation, stomach pain and fatigue
10.1056/NEJMoa1509225 68 Powell-WileyT
Avoid injecting into areas of active inflammation, bruising, or tenderness from previous doses